<DOC>
	<DOCNO>NCT02410330</DOCNO>
	<brief_summary>In acute coronary artery disease , pre-clinical study indicate , continuous infusion intravenous perfluorocarbon contain microbubbles , ultrasonic power deliver diagnostic ultrasound transducer capable restore microcirculatory flow improve epicardial recanalization rate obtain conventional therapy , process know Sonothrombolysis . The investigator propose examine feasibility , safety efficacy ultrasound guide approach 100 patient ST segment elevation myocardial infarction ( STEMI ) .</brief_summary>
	<brief_title>Therapeutic Use Ultrasound Acute Coronary Artery Disease</brief_title>
	<detailed_description>In acute coronary artery disease , pre-clinical study indicate , continuous infusion intravenous perfluorocarbon contain microbubbles , ultrasonic power deliver diagnostic ultrasound transducer capable restore microcirculatory flow improve epicardial recanalization rate obtain conventional therapy , process know Sonothrombolysis . Since diagnostic ultrasound intravenous infusion microbubbles Class I indication assess regional global leave ventricular function risk area patient ST segment elevation myocardial infarction ( STEMI ) . The investigator propose examine effectiveness microvascular sonothrombolysis . A total 100 patient acute STEMI randomize receive diagnostic ultrasound guide high mechanical index ( MI ) impulses different approach apply within outside risk area continuous infusion intravenous 3 % Definity® placebo . The different ultrasound regimen : Group I - custom design high mechanical index ( MI ) impulses 4-20 usec &gt; 1.0 MI design 1.7 MHz S5-1 transducer ; Group II - repeat diagnostic high MI impulse ( &lt; 2 usec pulse duration ; MI=1.0 whenever low MI perfusion image detected microbubbles within microvasculature ; Group III ( control ) , limited diagnostic high MI impulse ( n &lt; 5 per patient ) apply assess myocadial perfusion percutaneous coronary intervention ( PCI ) . All patient receive conventional PCI approach , include 325 milligram Aspirin , 600 milligram Clopidogrel , heparin bolus ( 5000 unit ) , follow primary PCI use glycoprotein 2b/3a inhibitor anti-thrombotic agent use establish protocol . Besides angiographic recanalization rate time presentation catheterization laboratory , patient magnetic resonance exam perform 72-96 hour post infarcton quantify myocardial salvagability index . Quantitative assessment ejection fraction make time well.Overall survival ( OS ) , define time start treatment death cause , evaluated.Comparisons three group make door dilation time , survival , angiographic recanalization rate ( ARR ) initial angiography , reduction infarct size determine salvagability index ( SI ) magnetic resonance image 72-96 hour post STEMI . Left ventricular function perfusion parameter echocardiography also evaluate , 72-96 hour 6 month subject .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Age ≥30 year STEMI less 12 hour chest pain onset . Eligible emergent PCI therapy . No contraindication hypersensitivity ultrasound contrast agent Known suspected hypersensitivity ultrasound contrast agent use study . Cardiogenic Shock . Life expectancy less two month terminally ill . Known bleed diathesis contraindication glycoprotein 2b/3a inhibitor , anticoagulant , aspirin . Known large right leave intracardiac shunt severe pulmonary hypertension . Patients receive thrombolytic therapy previously enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Therapeutic ultrasound</keyword>
	<keyword>Angiographic recanalization rate</keyword>
	<keyword>Salvagability index</keyword>
	<keyword>Sonothrombolysis</keyword>
</DOC>